Increased expression of DNMT1, DNMT3A, and DNMT3B was found in various cancers such as breast cancer, pancreatic cancer, lung cancer, hematological malignancies, and head and neck squamous cell carcinoma [28,33,34]. Here, DNMT3A is linked to hematologic disorder.